Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Efficacy Proof of Concept for Allogeneic CD123 Targeting CAR T-Cells Against Primary Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Efficient Control of Tumor Progression in PDX Model and Potential Loss of CD123 Expression in Relapsed Disease

Blood (2019) 134 (Supplement_1): 2659.

https://doi.org/10.1182/blood-2019-126869

Published: 2019

Journal Articles

Targeting Wnt/β-Catenin and BCL-2, Two Critical Survival Factors, Synergistically Induces Apoptosis in AML Via Rac1-Mediated MCL-1 Inhibition

Xiangmeng Wang, Po Yee Mak, Wencai Ma, Xiaoping Su, PhD, Hong Mu, MD PhD, Wenjing Tao, Michael Andreeff, MD PhD, Bing Z Carter, PhD

Blood (2018) 132 (Supplement 1): 1442.

https://doi.org/10.1182/blood-2018-99-118367

Published: 2018

Journal Articles

Targeting Aggregation of Wilde-Type p53 and Mutant p53 with ReACp53 As a Novel Therapeutic Concept for AML

Jianfang Zeng, MD PhD, Alice Soragni, PhD, Jo Ishizawa, MDPhD, Vivian Ruvolo, MS, Christopher B. Benton, MD, Teresa McQueen, MS, Peter Ruvolo, PhD, Yuan Qi, PhD, Xiaoping Su, PhD, Jared Burks, PhD, David S. Eisenberg, PhD, Michael Andreeff, MD PhD

Blood (2016) 128 (22): 3944.

https://doi.org/10.1182/blood.V128.22.3944.3944

Published: 2016

Journal Articles

Archetypes of AML Defined Using Whole Exome Sequencing and Clinical Characteristics in a Diverse Group of Patients

Blood (2016) 128 (22): 597.

https://doi.org/10.1182/blood.V128.22.597.597

Published: 2016

Journal Articles

Developing Therapeutic Strategies for CLL with Mutant p53

Hun Ju Lee, MD, Miguel Gallardo, PhD, Xiaorui Zhang, BS, Huaxian Ma, BS, Alfonso Quintas-Cardama, MD, Yuan Qi, Xiaoping Su, PhD, Sean M. Post, PhD

Blood (2015) 126 (23): 2476.

https://doi.org/10.1182/blood.V126.23.2476.2476

Published: 2015

Journal Articles

hnRNP K Is a Novel Haploinsufficient Tumor Suppressor at the 9q21.32 Locus That Defines a Subset of AML

Miguel Gallardo, PhD, Hun Ju Lee, MD, Xiaorui Zhang, BS, Carlos E. Bueso-Ramos, MD, Laura Pageon, Mark McArthur, Asha Multani, Aziz Nazha, MD, Taghi Manshouri, PhD, Jan Parker-Thornburg, Peter Hu, Yuan Qi, Xiaoping Su, PhD, Inmaculada Rapado, Alfonso Quintás-Cardama, Steven M. Kornblau, MD, Joaquin Martinez-López, MDPhD, Sean M. Post, PhD

Blood (2015) 126 (23): 439.

https://doi.org/10.1182/blood.V126.23.439.439

Published: 2015

Journal Articles

Efficacy of Novel Glutaminase Inhibitor CB-839 in Acute Myeloid Leukemia

Polina Matre, PhD, Maryam Shariati, Juliana Velez, Yuan Qi, Sergej Konoplev, MD PhD, Xiaoping Su, PhD, Courtney D. DiNardo, MD, Naval Daver, MD, Ravi Majeti, MD PhD, Michael Andreeff, MD PhD, Steven M. Chan, MD PhD, Marina Konopleva, MD PhD

Blood (2014) 124 (21): 3763.

https://doi.org/10.1182/blood.V124.21.3763.3763

Published: 2014

Journal Articles

Genome-Wide Mapping and Subtype Classification of Long Non-Coding RNA in Acute Myeloid Leukemia

Rong Chen, PhD, Gabriel G Malouf, MD PhD, Jianping Zhang, PhD, Xuelin Huang, PhD, John N Weinstein, MD PhD, Jean-Philippe Spano, MD PhD, Jeffrey J. Molldrem, MD, William Plunkett, PhD, Xiaoping Su, PhD

Blood (2014) 124 (21): 2355.

https://doi.org/10.1182/blood.V124.21.2355.2355

Published: 2014

Journal Articles

Transcriptome Sequence Analysis of Pediatric Acute Megakaryoblastic Leukemia Identifies An Inv(16)(p13.3;q24.3)-Encoded CBFA2T3-GLIS2 Fusion Protein As a Recurrent Lesion in 39% of Non-Infant Cases: A Report From the St. Jude Children's Research Hospital – Washington University Pediatric Cancer Genome Project

Blood (2011) 118 (21): 757.

https://doi.org/10.1182/blood.V118.21.757.757

Published: 2011

Journal Articles

High-Resolution SNP-Array Profiling of Chronic Lymphocytic Leukemia

Jennifer Edelmann, MD, Karlheinz Holzmann, PhD, W.M. Michael Kühn, MD, Lars Bullinger, MD, Ina Radtke, MD, PhD, Xiaoping Su, PhD, Jing Ma, Ph.D., Dirk Winkler, MD, Andreas Buehler, Michael Hallek, M.D., James R. Downing, MD, Stephan Stilgenbauer, MD, Hartmut Doehner, MD

Blood (2010) 116 (21): 50.

https://doi.org/10.1182/blood.V116.21.50.50

Published: 2010

Journal Articles

Acute Lymphoblastic Leukemia-Associated PAX5 Mutations Induce Aberrant B Cell Development

Joy Nakitandwe, PhD., Shann-Ching Chen, PhD., Noel T. Lenny, PhD., Christopher B. Miller, PhD., Xiaoping Su, PhD., Charles G. Mullighan, MD, PhD., James R. Downing, MD.

Blood (2010) 116 (21): 10.

https://doi.org/10.1182/blood.V116.21.10.10

Published: 2010

Journal Articles

High-Resolution Genomic Profiling of Adult and Pediatric Core Binding Factor Acute Myeloid Leukemia Reveals New Recurrent Genomic Aberrations

Blood (2010) 116 (21): 849.

https://doi.org/10.1182/blood.V116.21.849.849

Published: 2010

Journal Articles

Next Generation Transcriptomic Resequencing Identifies Novel Genetic Alterations in High-Risk (HR) Childhood Acute Lymphoblastic Leukemia (ALL): A Report From the Children's Oncology Group (COG) HR ALL TARGET Project.

Blood (2009) 114 (22): 704.

https://doi.org/10.1182/blood.V114.22.704.704

Published: 2009

Journal Articles

Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia

Charles G Mullighan, MBBS(Hons), MSc, MD, Letha A Phillips, BS, Xiaoping Su, PhD, Jing Ma, PhD, Christopher B Miller, BS, James R. Downing, MD

Blood (2008) 112 (11): 429.

https://doi.org/10.1182/blood.V112.11.429.429

Published: 2008

Journal Articles

Deletion of IKZF1 (Ikaros) Predicts Poor Outcome and Impaired Maturation in B-Progenitor Acute Lymphoblastic Leukemia

Blood (2008) 112 (11): 427.

https://doi.org/10.1182/blood.V112.11.427.427

Published: 2008

Journal Articles

Pax5 Haploinsufficiency Cooperates with BCR-ABL1 to Induce Acute Lymphoblastic Leukemia

ChristoPher B Miller, BS, Charles G Mullighan, MBBS(Hons), MSc, MD, Xiaoping Su, PhD, Jing Ma, PhD, Michael Wang, PhD, Jinghui Zhang, Ph.D., Richard T Williams, MD, PhD, James R. Downing, MD

Blood (2008) 112 (11): 293.

https://doi.org/10.1182/blood.V112.11.293.293

Published: 2008

Journal Articles

Haploinsufficiency of Ebf1 Collaborates with BCR-ABL1 to Decrease the Latency of Acute Lymphoblastic Leukemia.

Salil Goorha, MD, Noel T. Lenny, PhD, Christopher B Miller, BS, S. Scott Perry, PhD, Xiaoping Su, PhD, Richard T Williams, MD, PhD, Charles G Mullighan, MBBS(Hons), MSc, MD, James R. Downing, MD

Blood (2008) 112 (11): 3363.

https://doi.org/10.1182/blood.V112.11.3363.3363

Published: 2008

Journal Articles

The Cation Transporter SLC22A16 Is Expressed in Pediatric Acute Lymphoblastic Leukemia

Jeffrey A. Moscow, MD, Terzah M. Horton, MD, PhD, Abigail Daily, Xiaoping Su, PhD

Blood (2008) 112 (11): 4471.

https://doi.org/10.1182/blood.V112.11.4471.4471

Published: 2008

Journal Articles

Genome-Wide Analysis of Genetic Alterations in Chronic Myelogenous Leukemia.

Charles G Mullighan, MBBS(Hons), MSC, MD, Ina Radtke, PhD, Jinghui Zhang, Ph.D., Letha A. Phillips, BS, Xiaoping Su, PhD, Jing Ma, PhD, Zhongling Cai, Timothy P. Hughes, MBBS, PhD, Deborah L White, PhD, Andrew W. Roberts, MBBS, PhD, Lynda J. Campbell, MBBS, FRCPA, Sheila A. Shurtleff, James R. Downing, MD

Blood (2008) 112 (11): 1089.

https://doi.org/10.1182/blood.V112.11.1089.1089

Published: 2008

Journal Articles

ERG Deletions Define a Novel Subtype of B-Progenitor Acute Lymphoblastic Leukemia.

Charles G. Mullighan, MBBS, MD, Christopher B. Miller, BS, Xiaoping Su, PhD, Ina Radtke, MD, PhD, James Dalton, BS, Guanchung Song, PhD, Xiaodong Zhou, MS, Ching-Hon Pui, MD, Sheila A. Shurtleff, PhD, James R. Downing, MD

Blood (2007) 110 (11): 691.

https://doi.org/10.1182/blood.V110.11.691.691

Published: 2007

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Efficacy Proof of Concept for Allogeneic CD123 Targeting CAR T-Cells Against Primary Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Efficient Control of Tumor Progression in PDX Model and Potential Loss of CD123 Expression in Relapsed Disease

Targeting Wnt/β-Catenin and BCL-2, Two Critical Survival Factors, Synergistically Induces Apoptosis in AML Via Rac1-Mediated MCL-1 Inhibition

Targeting Aggregation of Wilde-Type p53 and Mutant p53 with ReACp53 As a Novel Therapeutic Concept for AML

Archetypes of AML Defined Using Whole Exome Sequencing and Clinical Characteristics in a Diverse Group of Patients

Developing Therapeutic Strategies for CLL with Mutant p53

hnRNP K Is a Novel Haploinsufficient Tumor Suppressor at the 9q21.32 Locus That Defines a Subset of AML

Efficacy of Novel Glutaminase Inhibitor CB-839 in Acute Myeloid Leukemia

Genome-Wide Mapping and Subtype Classification of Long Non-Coding RNA in Acute Myeloid Leukemia

High-Resolution SNP-Array Profiling of Chronic Lymphocytic Leukemia

Acute Lymphoblastic Leukemia-Associated PAX5 Mutations Induce Aberrant B Cell Development

High-Resolution Genomic Profiling of Adult and Pediatric Core Binding Factor Acute Myeloid Leukemia Reveals New Recurrent Genomic Aberrations

Next Generation Transcriptomic Resequencing Identifies Novel Genetic Alterations in High-Risk (HR) Childhood Acute Lymphoblastic Leukemia (ALL): A Report From the Children's Oncology Group (COG) HR ALL TARGET Project.

Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia

Deletion of IKZF1 (Ikaros) Predicts Poor Outcome and Impaired Maturation in B-Progenitor Acute Lymphoblastic Leukemia

Pax5 Haploinsufficiency Cooperates with BCR-ABL1 to Induce Acute Lymphoblastic Leukemia

Haploinsufficiency of Ebf1 Collaborates with BCR-ABL1 to Decrease the Latency of Acute Lymphoblastic Leukemia.

The Cation Transporter SLC22A16 Is Expressed in Pediatric Acute Lymphoblastic Leukemia

Genome-Wide Analysis of Genetic Alterations in Chronic Myelogenous Leukemia.

ERG Deletions Define a Novel Subtype of B-Progenitor Acute Lymphoblastic Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only